Item(by='jfarlow', descendants=None, kids=None, score=None, time=1608325884, title=None, item_type='comment', url=None, parent=25470841, text='The number of [nucleic-acid-delivered] gene therapies in Phase II &amp; Phase III trials right now is huge - because of this progress in delivery [of nucleic acids].  Gene therapies for the eye, for hemophilia, for sickle cell, many many cancer therapies all rely on the ability to &#x27;deliver&#x27; nucleic acid payloads to cells.  Of those, only 3 or 4 have been approved - and all in the past 2 years, but there are a huge number that are behind that tip of the iceberg - quite precisely because it&#x27;s relatively straightforward to do &#x27;same thing but with a different sequence&#x27; once the first one works.')